CTRI/2019/05/019381已完成未知
Optimal dose of Neostigmine for effective reversal of vecuronium induced neuromuscular block based on clinical signs - A Randomised double blind clinical trial
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 134
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •ASA physical Status I and II
排除标准
- •Patient Refusal
- •Patients with Hepatic or Renal Dysfunction
- •Patients with neuromuscular disorders
- •Difficult airway
- •Patients receiving medications which influence neuromuscular blockade
研究者
相似试验
已完成
4 期
The effect of routine reversal of neuromuscular blockade on surgical conditions for thyroid surgeryACTRN12611000914965Emma Boden50
已完成
不适用
Appropriate Dose of Neostigmine for Reversal of Rocuronium and CisatracuriumObservation of Neuromuscular BlockNCT01885715Seoul National University Hospital112
Unknown
4 期
Different Doses of Neostigmine for Reversal of Moderate Neuromuscular Blockade in ChildrenNeuromuscular BlockadeNeuromuscular Block, ResidualNeuromuscular Block ProlongedNCT05053594Pontificia Universidade Catolica de Sao Paulo60
招募中
2 期
The effect of adding different doses of neostigmine in peribulbar block for cataract surgeryIRCT20210106049952N1Research Institute of Ophthalmology60
尚未招募
1 期
Safety and efficacy studies of neostigmine administration as a topical ophthalmic solution for diagnosing ocular myasthenia gravis in adults presenting with ptosisMyasthenia gravisACTRN12624000545561Faculty of Medicine, Chulalongkorn University24